Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics
| By: | John J Cush; Kathryn H. Dao |
| Publisher: | Elsevier Health Sciences (US) |
| Print ISBN: | 9781455750658 |
| eText ISBN: | 9781455750597 |
| Edition: | 0 |
| Copyright: | 2012 |
| Format: | Reflowable |
Lifetime - $100.79
eBook Features
Instant Access
Purchase and read your book immediately
Read Offline
Access your eTextbook anytime and anywhere
Study Tools
Built-in study tools like highlights and more
Read Aloud
Listen and follow along as Bookshelf reads to you
Details
Table of Contents
Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.